Provided by Tiger Trade Technology Pte. Ltd.

Merck

148.46
-1.8700-1.24%
Post-market: 148.460.00000.00%17:24 EDT
Volume:10.89M
Turnover:1.62B
Market Cap:366.28B
PE:116.64
High:149.60
Open:148.41
Low:146.28
Close:150.33
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.33
T/O Rate:0.44%
Dividend:3.32
Dividend Rate:2.24%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.73
PE(LYR):20.39

Loading ...

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
56 mins ago

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Yesterday

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Yesterday

Merck KGaA (0O14) Gets a Hold from Barclays

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Yesterday

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
Sep 04

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

TIPRANKS
·
Sep 04

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Dow Jones
·
Sep 04

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Sep 03

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Movement Alert|Merck Rises 3.65% in Pre-Market Trading, HSBC Upgrades to Buy as mRNA Cancer Vaccine Momentum Continues

Market Focus
·
Sep 02

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.
·
Sep 02

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
Sep 02

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Sep 01